ATC code L01
From Self-sufficiency
| ATC codes |
|---|
| L Antineoplastic and immunomodulating agents |
| L01 Antineoplastic agents |
| L02 Endocrine therapy |
| L03 Immunostimulants |
| L04 Immunosuppressants |
|
|
ATC code L01 Antineoplastic agents is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup L01 is part of the anatomical group L Antineoplastic and immunomodulating agents.[1]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: QL01...[2] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
Contents
L01A Alkylating agents
L01AA Nitrogen mustard analogues
- L01AA01 Cyclophosphamide
- L01AA02 Chlorambucil
- L01AA03 Melphalan
- L01AA05 Chlormethine
- L01AA06 Ifosfamide
- L01AA07 Trofosfamide
- L01AA08 Prednimustine
- L01AA09 Bendamustine
L01AB Alkyl sulfonates
- L01AB01 Busulfan
- L01AB02 Treosulfan
- L01AB03 Mannosulfan
L01AC Ethylene imines
- L01AC01 Thiotepa
- L01AC02 Triaziquone
- L01AC03 Carboquone
L01AD Nitrosoureas
- L01AD01 Carmustine
- L01AD02 Lomustine
- L01AD03 Semustine
- L01AD04 Streptozocin
- L01AD05 Fotemustine
- L01AD06 Nimustine
- L01AD07 Ranimustine
L01AG Epoxides
- L01AG01 Etoglucid
L01AX Other alkylating agents
- L01AX01 Mitobronitol
- L01AX02 Pipobroman
- L01AX03 Temozolomide
- L01AX04 Dacarbazine
L01B Antimetabolites
L01BA Folic acid analogues
- L01BA01 Methotrexate
- L01BA03 Raltitrexed
- L01BA04 Pemetrexed
- L01BA05 Pralatrexate
L01BB Purine analogues
- L01BB02 Mercaptopurine
- L01BB03 Tioguanine
- L01BB04 Cladribine
- L01BB05 Fludarabine
- L01BB06 Clofarabine
- L01BB07 Nelarabine
L01BC Pyrimidine analogues
- L01BC01 Cytarabine
- L01BC02 Fluorouracil
- L01BC03 Tegafur
- L01BC04 Carmofur
- L01BC05 Gemcitabine
- L01BC06 Capecitabine
- L01BC07 Azacitidine
- L01BC08 Decitabine
- L01BC52 Fluorouracil, combinations
- L01BC53 Tegafur, combinations
L01C Plant alkaloids and other natural products
L01CA Vinca alkaloids and analogues
- L01CA01 Vinblastine
- L01CA02 Vincristine
- L01CA03 Vindesine
- L01CA04 Vinorelbine
- L01CA05 Vinflunine
L01CB Podophyllotoxin derivatives
- L01CB01 Etoposide
- L01CB02 Teniposide
L01CC Colchicine derivatives
- L01CC01 Demecolcine
L01CD Taxanes
- L01CD01 Paclitaxel
- L01CD02 Docetaxel
- L01CD03 Paclitaxel poliglumex
L01CX Other plant alkaloids and natural products
- L01CX01 Trabectedin
L01DA Actinomycines
- L01DA01 Dactinomycin
- L01DB01 Doxorubicin
- L01DB02 Daunorubicin
- L01DB03 Epirubicin
- L01DB04 Aclarubicin
- L01DB05 Zorubicin
- L01DB06 Idarubicin
- L01DB07 Mitoxantrone
- L01DB08 Pirarubicin
- L01DB09 Valrubicin
L01DC Other cytotoxic antibiotics
- L01DC01 Bleomycin
- L01DC02 Plicamycin
- L01DC03 Mitomycin
- L01DC04 Ixabepilone
L01X Other antineoplastic agents
L01XA Platinum compounds
- L01XA01 Cisplatin
- L01XA02 Carboplatin
- L01XA03 Oxaliplatin
- L01XA04 Satraplatin
L01XB Methylhydrazines
- L01XB01 Procarbazine
L01XC Monoclonal antibodies
- L01XC01 Edrecolomab
- L01XC02 Rituximab
- L01XC03 Trastuzumab
- L01XC04 Alemtuzumab
- L01XC05 Gemtuzumab
- L01XC06 Cetuximab
- L01XC07 Bevacizumab
- L01XC08 Panitumumab
- L01XC09 Catumaxomab
- L01XC10 Ofatumumab
L01XD Sensitizers used in photodynamic/radiation therapy
- L01XD01 Porfimer sodium
- L01XD03 Methyl aminolevulinate
- L01XD04 Aminolevulinic acid
- L01XD05 Temoporfin
- L01XD06 Efaproxiral
L01XE Protein kinase inhibitors
- L01XE01 Imatinib
- L01XE02 Gefitinib
- L01XE03 Erlotinib
- L01XE04 Sunitinib
- L01XE05 Sorafenib
- L01XE06 Dasatinib
- L01XE07 Lapatinib
- L01XE08 Nilotinib
- L01XE09 Temsirolimus
- L01XE10 Everolimus
- L01XE11 Pazopanib
- QL01XE90 Masitinib
- QL01XE91 Toceranib
L01XX Other antineoplastic agents
- L01XX01 Amsacrine
- L01XX02 Asparaginase
- L01XX03 Altretamine
- L01XX05 Hydroxycarbamide
- L01XX07 Lonidamine
- L01XX08 Pentostatin
- L01XX09 Miltefosine
- L01XX10 Masoprocol
- L01XX11 Estramustine
- L01XX14 Tretinoin
- L01XX16 Mitoguazone
- L01XX17 Topotecan
- L01XX18 Tiazofurine
- L01XX19 Irinotecan
- L01XX22 Alitretinoin
- L01XX23 Mitotane
- L01XX24 Pegaspargase
- L01XX25 Bexarotene
- L01XX27 Arsenic trioxide
- L01XX29 Denileukin diftitox
- L01XX32 Bortezomib
- L01XX33 Celecoxib
- L01XX35 Anagrelide
- L01XX36 Oblimersen
- L01XX37 Sitimagene ceradenovec
- L01XX38 Vorinostat
- L01XX39 Romidepsin
L01XY Combinations of antineoplastic agents
References
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />cs:ATC kód L01 es:Anexo:Código ATC L01 hu:ATC L01 – Daganatellenes szerek pl:ATC (L01) ro:Cod ATC L01 sv:ATC-kod L01: Cytostatiska/cytotoxiska medel
th:ATC รหัส L01- ↑ "ATC Index". WHO Collaborating Centre for Drug Statistics Methodology.
- ↑ "ATCvet Index". WHO Collaborating Centre for Drug Statistics Methodology.
